{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T06:28:07Z","timestamp":1767421687243},"reference-count":36,"publisher":"Pharmaceutical Society of Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2018]]},"DOI":"10.1248\/bpb.b17-00594","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T22:25:49Z","timestamp":1517437549000},"page":"182-189","source":"Crossref","is-referenced-by-count":13,"title":["The Role of Interleukin-19 in Contact Hypersensitivity"],"prefix":"10.1248","volume":"41","author":[{"given":"Yasuyuki","family":"Fujimoto","sequence":"first","affiliation":[{"name":"Laboratory of Veterinary Pharmacology, Division of Veterinary Science, Osaka Prefecture University Graduate School of Life and Environmental Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Fujita","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Toxicology, Department of Pharmaceutical Sciences, Ritsumeikan University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Kuramoto","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Pharmacology, Setsunan University Faculty of Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Kuwamura","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pathology, Division of Veterinary Science, Osaka Prefecture University Graduate School of Life and Environmental Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Izawa","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pathology, Division of Veterinary Science, Osaka Prefecture University Graduate School of Life and Environmental Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Nishiyama","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pharmacology, Division of Veterinary Science, Osaka Prefecture University Graduate School of Life and Environmental Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsuho","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pharmacology, Division of Veterinary Science, Osaka Prefecture University Graduate School of Life and Environmental Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidemitsu","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pharmacology, Division of Veterinary Science, Osaka Prefecture University Graduate School of Life and Environmental Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadayoshi","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pharmacology, Division of Veterinary Science, Osaka Prefecture University Graduate School of Life and Environmental Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasu-Taka","family":"Azuma","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pharmacology, Division of Veterinary Science, Osaka Prefecture University Graduate School of Life and Environmental Science"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Steinfelder S, O\u2019Regan NL, Hartmann S. Diplomatic assistance: can helminth-modulated macrophages act as treatment for inflammatory disease? PLOS Pathog.<\/i>, 12<\/b>, e1005480 (2016)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Liang Y, Kwota Z, Sun J. Intrahepatic regulation of antiviral T cell responses at initial stages of viral infection. Int. Immunopharmacol.<\/i>, 39<\/b>, 106\u2013112 (2016).","DOI":"10.1016\/j.intimp.2016.07.021"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Maeda N, Yamada C, Takahashi A, Kuroki K, Maenaka K. Therapeutic application of human leukocyte antigen-G1 improves atopic dermatitis-like skin lesions in mice. Int. Immunopharmacol.<\/i>, 50<\/b>, 202\u2013207 (2017).","DOI":"10.1016\/j.intimp.2017.06.026"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Martins JD, Maciel EA, Silva A, Ferreira I, Ricardo F, Domingues P, Neves BM, Domingues MR, Cruz MT. Phospholipidomic profile variation on THP-1 cells exposed to skin or respiratory sensitizers and respiratory irritant. J. Cell. Physiol.<\/i>, 231<\/b>, 2639\u20132651 (2016).","DOI":"10.1002\/jcp.25365"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Li X, Wang X, Jiang H, Zhang G, Tan R, Sun Y, Wu X, Tan R, Xu Q. Herpetol ameliorates allergic contact dermatitis through regulating T-lymphocytes. Int. Immunopharmacol.<\/i>, 40<\/b>, 131\u2013138 (2016).","DOI":"10.1016\/j.intimp.2016.08.025"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Christensen AD, Haase C. Immunological mechanisms of contact hypersensitivity in mice. APMIS<\/i>, 120<\/b>, 1\u201327 (2012).","DOI":"10.1111\/j.1600-0463.2011.02832.x"},{"key":"7","unstructured":"7) Xu H, DiIulio NA, Fairchild RL. T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4\/Il-10-producing (Th2) negative regulatory CD4+ T cells. J. Exp. Med.<\/i>, 183<\/b>, 1001\u20131012 (1996)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Azuma YT, Matsuo Y, Kuwamura M, Yancopoulos GD, Valenzuela DM, Murphy AJ, Nakajima H, Karow M, Takeuchi T. Interleukin-19 protects mice from innate-mediated colonic inflammation. Inflamm. Bowel Dis.<\/i>, 16<\/b>, 1017\u20131028 (2010).","DOI":"10.1002\/ibd.21151"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Matsuo Y, Azuma YT, Kuwamura M, Kuramoto N, Nishiyama K, Yoshida N, Ikeda Y, Fujimoto Y, Nakajima H, Takeuchi T. Interleukin 19 reduces inflammation in chemically induced experimental colitis. Int. Immunopharmacol.<\/i>, 29<\/b>, 468\u2013475 (2015).","DOI":"10.1016\/j.intimp.2015.10.011"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Fujimoto Y, Azuma YT, Matsuo Y, Kuwamura M, Kuramoto N, Miki M, Azuma N, Teramoto M, Nishiyama K, Izawa T, Nakajima H, Takeuchi T. Interleukin-19 contributes as a protective factor in experimental Th2-mediated colitis. Naunyn Schmiedebergs Arch. Pharmacol.<\/i>, 390<\/b>, 261\u2013268 (2017).","DOI":"10.1007\/s00210-016-1329-0"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Gallagher G, Dickensheets H, Eskdale J, Izotova LS, Mirochnitchenko OV, Peat JD, Vazquez N, Pestka S, Donnelly RP, Kotenko SV. Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun.<\/i>, 1<\/b>, 442\u2013450 (2000).","DOI":"10.1038\/sj.gene.6363714"},{"key":"12","unstructured":"12) Wolk K, Kunz S, Asadullah K, Sabat R. Cutting edge: immune cells as sources and targets of the IL-10 family members? J. Immunol.<\/i>, 168<\/b>, 5397\u20135402 (2002)."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Kunz S, Wolk K, Witte E, Witte K, Doecke WD, Volk HD, Sterry W, Asadullah K, Sabat R. Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs. Exp. Dermatol.<\/i>, 15<\/b>, 991\u20131004 (2006).","DOI":"10.1111\/j.1600-0625.2006.00516.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Azuma YT, Matsuo Y, Nakajima H, Yancopoulos GD, Valenzuela DM, Murphy AJ, Karow M, Takeuchi T. Interleukin-19 is a negative regulator of innate immunity and critical for colonic protection. J. Pharmacol. Sci.<\/i>, 115<\/b>, 105\u2013111 (2011).","DOI":"10.1254\/jphs.10R02CR"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Liao SC, Cheng YC, Wang YC, Wang CW, Yang SM, Yu CK, Shieh CC, Cheng KC, Lee MF, Chiang SR, Shieh JM, Chang MS. IL-19 induced Th2 cytokines and was up-regulated in asthma patients. J. Immunol.<\/i>, 173<\/b>, 6712\u20136718 (2004).","DOI":"10.4049\/jimmunol.173.11.6712"},{"key":"16","unstructured":"16) Gallagher G, Eskdale J, Jordan W, Peat J, Campbell J, Boniotto M, Lennon GP, Dickensheets H, Donnelly RP. Human interleukin-19 and its receptor: a potential role in the induction of Th2 responses. Int. Immunopharmacol.<\/i>, 4<\/b>, 615\u2013626 (2004)."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Witte E, Kokolakis G, Witte K, Philipp S, Doecke WD, Babel N, Wittig BM, Warszawska K, Kurek A, Erdmann-Keding M, Kunz S, Asadullah K, Kadin ME, Volk HD, Sterry W, Wolk K, Sabat R. IL-19 is a component of the pathogenetic IL-23\/IL-17 cascade in psoriasis. J. Invest. Dermatol.<\/i>, 134<\/b>, 2757\u20132767 (2014).","DOI":"10.1038\/jid.2014.308"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Li HH, Lin YC, Chen PJ, Hsiao CH, Lee JY, Chen WC, Tzung TY, Wu JC, Chang MS. Interleukin-19 upregulates keratinocyte growth factor and is associated with psoriasis. Br. J. Dermatol.<\/i>, 153<\/b>, 591\u2013595 (2005).","DOI":"10.1111\/j.1365-2133.2005.06665.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Otkjaer K, Kragballe K, Funding AT, Clausen JT, Noerby PL, Steiniche T, Iversen L. The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis. Br. J. Dermatol.<\/i>, 153<\/b>, 911\u2013918 (2005).","DOI":"10.1111\/j.1365-2133.2005.06800.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Azuma YT, Hagi K, Shintani N, Kuwamura M, Nakajima H, Hashimoto H, Baba A, Takeuchi T. PACAP provides colonic protection against dextran sodium sulfate induced colitis. J. Cell. Physiol.<\/i>, 216<\/b>, 111\u2013119 (2008).","DOI":"10.1002\/jcp.21381"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Azuma YT, Hayashi S, Nishiyama K, Kita S, Mukai K, Nakajima H, Iwamoto T, Takeuchi T. Na+<\/sup>\/Ca2+<\/sup> exchanger-heterozygote knockout mice display increased relaxation in gastric fundus and accelerated gastric transit in vivo.<\/i> Neurogastroenterol. Motil.<\/i>, 28<\/b>, 827\u2013836 (2016).","DOI":"10.1111\/nmo.12779"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Azuma YT, Nishiyama K, Matsuo Y, Kuwamura M, Morioka A, Nakajima H, Takeuchi T. PPAR\u03b1 contributes to colonic protection in mice with DSS-induced colitis. Int. Immunopharmacol.<\/i>, 10<\/b>, 1261\u20131267 (2010).","DOI":"10.1016\/j.intimp.2010.07.007"},{"key":"23","unstructured":"23) Kinjo T, Azuma YT, Nishiyama K, Fujimoto Y, Miki M, Kuramoto N. Intestinal IL-17 expression in canine inflammatory bowel disease. Int. J. Vet. Health Sci. Res.<\/i>, (2018), in press."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Fujimoto Y, Tsuneyama K, Kuramoto N, Hayashi S, Yoshida N, Morioka A, Teramoto M, Nakajima H, Takeuchi T, Azuma YT. Exacerbated experimental pancreatitis in interleukin-19 knockout mice. Glob. Drugs Therap.<\/i>, 2<\/b>, 1\u20135 (2017).","DOI":"10.15761\/GDT.1000S1005"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Broggi A, Cigni C, Zanoni I, Granucci F. Preparation of single-cell suspensions for cytofluorimetric analysis from different mouse skin regions. J. Vis. Exp.<\/i>, 110<\/b>, e52589 (2016).","DOI":"10.3791\/52589"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Nishimura K, Aoyanagi N, Uchino E, Itabashi Y. Influence of hot spring water on fatty acid composition of skin surface lipids in hairless mouse model of atopic dermatitis. Biol. Pharm. Bull.<\/i>, 39<\/b>, 1718\u20131722 (2016).","DOI":"10.1248\/bpb.b16-00275"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Matsuoka T, Kurohane K, Suzuki W, Ogawa E, Kobayashi K, Imai Y. Dibutyl maleate and dibutyl fumarate enhance contact sensitization to fluorescein isothiocyanate in mice. Biol. Pharm. Bull.<\/i>, 39<\/b>, 272\u2013277 (2016).","DOI":"10.1248\/bpb.b15-00683"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, Homma I, Sekikawa K, Asano M, Iwakura Y. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity<\/i>, 17<\/b>, 375\u2013387 (2002).","DOI":"10.1016\/S1074-7613(02)00391-6"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) He D, Wu L, Kim HK, Li H, Elmets CA, Xu H. IL-17 and IFN-gamma mediate the elicitation of contact hypersensitivity responses by different mechanisms and both are required for optimal responses. J. Immunol.<\/i>, 183<\/b>, 1463\u20131470 (2009).","DOI":"10.4049\/jimmunol.0804108"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Jiang X, Park CO, Geddes Sweeney J, Yoo MJ, Gaide O, Kupper TS. Dermal \u03b3\u03b4 T cells do not freely re-circulate out of skin and produce IL-17 to promote neutrophil infiltration during primary contact hypersensitivity. PLOS ONE<\/i>, 12<\/b>, e0169397 (2017).","DOI":"10.1371\/journal.pone.0169397"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Myles IA, Fontecilla NM, Valdez PA, Vithayathil PJ, Naik S, Belkaid Y, Ouyang W, Datta SK. Signaling via<\/i> the IL-20 receptor inhibits cutaneous production of IL-1\u03b2 and IL-17A to promote infection with methicillin-resistant Staphylococcus aureus<\/i>. Nat. Immunol.<\/i>, 14<\/b>, 804\u2013811 (2013).","DOI":"10.1038\/ni.2637"},{"key":"32","unstructured":"32) Kitani A, Fuss IJ, Nakamura K, Schwartz OM, Usui T, Strober W. Treatment of experimental (trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-beta1 plasmid: TGF-beta1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor beta2 chain downregulation. J. Exp. Med.<\/i>, 192<\/b>, 41\u201352 (2000)."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Heller F, Fuss IJ, Nieuwenhuis EE, Blumberg RS, Strober W. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity<\/i>, 17<\/b>, 629\u2013638 (2002).","DOI":"10.1016\/S1074-7613(02)00453-3"},{"key":"34","unstructured":"34) Boirivant M, Fuss IJ, Chu A, Strober W. Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J. Exp. Med.<\/i>, 188<\/b>, 1929\u20131939 (1998)."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Cowden JM, Zhang M, Dunford PJ, Thurmond RL. The histamine H4 receptor mediates inflammation and pruritus in Th2-dependent dermal inflammation. J. Invest. Dermatol.<\/i>, 130<\/b>, 1023\u20131033 (2010).","DOI":"10.1038\/jid.2009.358"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Shimizuhira C, Otsuka A, Honda T, Kitoh A, Egawa G, Nakajima S, Nakashima C, Watarai H, Miyachi Y, Kabashima K. Natural killer T cells are essential for the development of contact hypersensitivity in BALB\/c mice. J. Invest. Dermatol.<\/i>, 134<\/b>, 2709\u20132718 (2014).","DOI":"10.1038\/jid.2014.200"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/41\/2\/41_b17-00594\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T03:06:52Z","timestamp":1570676812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/41\/2\/41_b17-00594\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b17-00594","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}